UK-500,001, a potent selective inhibitor of phosphodiesterase type 4 (PDE4) designed for inhaled delivery, inhibits TNF-a, MIP-1b and LTB4 released from native blood cells.

Trevethick, M, Banner, K, Ballard, S, Barnard, A, Lewis, A, Sims, G, Mansfield, F, Brown, C, Salmon, G, Clark, N, and others. (2007) UK-500,001, a potent selective inhibitor of phosphodiesterase type 4 (PDE4) designed for inhaled delivery, inhibits TNF-a, MIP-1b and LTB4 released from native blood cells. In: American Thoracic Society Meeting, 2007, San Franscisco International Conference. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:49258)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.

Item Type:	Conference or workshop item (Poster)
Subjects:	Q Science
Divisions:	Divisions > Division of Natural Sciences > Biosciences
Depositing User:	Frances Mansfield
Date Deposited:	07 Jul 2015 16:55 UTC
Last Modified:	16 Nov 2021 10:20 UTC
Resource URI:	https://kar.kent.ac.uk/id/eprint/49258 (The current URI for this page, for reference purposes)

University of Kent Author Information

Mansfield, F.

Creator's ORCID:
CReDIT Contributor Roles:

Depositors only (login required):

Download Statistics

Total unique views for this document in KAR since July 2020. For more details click on the image.